Unum Group UNM has agreed to divest its Medical Stop Loss business to Amynta Group. This move will help the insurer intensify its focus on its strategic growth priorities. The divestiture is estimated to be completed in the third quarter of 2024. Amynta Group is a leading insurance services provider. Following its acquisition, the stop-loss business will operate as a full-service managing general underwriter under Amynta Risk Solutions. The addition of Unum’s Medical Stop Loss business will enhance Amynta Group’s product portfolio and help it serve clients better with comprehensive solutions. John Doucette, CEO of Amynta Risk Solutions, stated, “Unum has built a strong stop-loss business, bringing great expertise and capabilities to the market. We will continue to invest in the business to drive growth and innovation in the medical stop loss market.” Unum is ranked as the leading disability income writer and the second-largest writer of voluntary business in the United States. The medical stop-loss business is part of Unum’s group disability line of business, which also includes long-term and short-term disability and fee-based service products. With this divestiture, the company intends to intensify its focus on leveraging enhanced capabilities to drive top-line growth and, in turn, achieve high single-digit bottom-line growth in 2024. Healthy in-force block growth, higher sales, strong persistency in group lines, growth of new product lines and favorable risk results should continue to drive Unum’s results. Shares of Unum have gained 11% year to date, outperforming the industry’s increase of 6.8%. Favorable sales trends and risk experience, strong persistency, an improving rate environment and a solid capital position continue to drive this Zacks Rank #3 (Hold) insurer. Zacks Investment Research Image Source: Zacks Investment Research Stocks to Consider Some top-ranked stocks from the insurance industry are HCI Group, Inc. HCI, Palomar Holdings PLMR and ProAssurance PRA, each sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here. HCI Group earnings surpassed estimates in each of the last four quarters, the average beat being 139.15%. In the past year, HCI has rallied 45.1%. The Zacks Consensus Estimate for HCI’s 2024 and 2025 earnings implies 57.6% and 4.3% year-over-year growth, respectively. Palomar’s earnings surpassed estimates in each of the last four quarters, the average earnings surprise being 15.10%. In the past year, PLMR’s stock has surged 45.5%. The Zacks Consensus Estimate for PLMR’s 2024 and 2025 earnings indicates 26% and 18% year-over-year growth, respectively. ProAssurance earnings surpassed estimates in two of the last four quarters and missed in the other two. In the past year, PRA’s stock has lost 28.1%. The Zacks Consensus Estimate for PRA’s 2024 and 2025 earnings suggests 371.4% and 72.6% year-over-year growth, respectively. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Unum Group (UNM):Free Stock Analysis Report ProAssurance Corporation (PRA):Free Stock Analysis Report HCI Group, Inc. (HCI):Free Stock Analysis Report Palomar Holdings, Inc. (PLMR):Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
Unum (UNM) to Divest Medical Stop Loss Business to Amynta Group
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...